Yifang Biological (688382.SH) released its first-quarter financial results, with a net loss attributable to shareholders of 57.5 million yuan.

Smart Financial News APP reported that Yifang Bioscience (688382.SH) disclosed its first quarter report for 2025. During the reporting period, the company achieved a revenue of 8.19 million yuan, a decrease of 4.85% year-on-year. The net profit attributable to the parent company was a loss of 57.5 million yuan, and the non-recurring net profit was a loss of 58.22 million yuan. The basic earnings per share is -0.10 yuan.